To provide an evidence for the effectiveness of hEnSC transplantation in AKI treatment, thepresent study was designed based on the hypothesis that administration of these cells canmodulate the expression levels of Bcl-2 and Tnf-α in the renal tissue fromcisplatin-induced AKI rats. The gene discussed is TNF; the disease is acute kidney injury.